Author:
Maes Marie-Berthe,Dubois Véronique,Brandt Inger,Lambeir Anne-Marie,Van der Veken Pieter,Augustyns Koen,Cheng Jonathan D.,Chen Xin,Scharpé Simon,De Meester Ingrid
Funder
Scientific Research-Flanders
Belgium; F.W.O.-Vlaanderen
Subject
Cell Biology,Immunology,Immunology and Allergy
Reference26 articles.
1. Prolyl peptidases: a serine protease subfamily with high potential for drug discovery;Rosenblum;Curr. Opin. Chem. Biol.,2003
2. Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV;Lambeir;Crit. Rev. Clin. Lab. Sci.,2003
3. Dipeptidyl peptidase IV inhibitors for the treatment of diabetes;Weber;J. Med. Chem.,2004
4. Talabostat. Oncolytic, hematopoietic agent, dipeptidyl-peptidase IV (CD26) inhibitor, fibroblast activation protein inhibitor;McIntyre;Drugs of the Future,2004
5. Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8;Abbott;Eur. J. Biochem.,2000
Cited by
69 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献